Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Salil Sharma of Kapoor Sharma and Company feels that one should exit Aurobindo Pharma.
Wockhardt has target of Rs 448, says Nooresh Mirani, AVP Technical of AMSEC Research.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Buy Wockhardt, says Rajesh Jain, EVP Reatail Research of Religare Sec.
On CNBC-TV18's new show Super Six, market gurus Arunesh Madan, Founder and Director of Augment Investment Pvt ltd, Abhijit Paul, Technical Analyst of Brics Securities ltd and Rajesh Jain, place their bets on two stocks each, thus offering investors a variety of options to choose from.
Invest in Wockhardt, says Salil Sharma of Kapur Sharma & Co.
Sell Reliance 800 put, says Hemen Kapadia, CEO, chartpundit.com.
Buy Wockhardt from a medium term perspective, says Hemen Kapadia, CEO, chartpundit.com.
Sun Pharma can rally upto Rs 512, says Salil Sharma, Kapur Sharma & Co. Salil Sahram Polycom.
Hemen Kapadia of chartpundit.com feels that Wockhardt looks like a decent opportunity. He advised buying with a target of Rs 410.
Super Six, a new show started by the CNBC-TV18, offer investors a chance to have a look at the stocks that can be added to their portfolio.
Buy Wockhardt, says Hemen Kapadia, chartpundit.com.
Sell Wockhardt, says Rajesh Jain, Independent Market Strategist, ECR.